Abstract：
AIM:Data on lung cancer survival are lacking in developing countries. Our objectives were to describe the survival of our lung cancer patients and to determine independent prognostic factors affecting survival. METHOD:All patients diagnosed with lung cancer from August 2007 to August 2010 were recruited from a single referral hospital of the state of Pahang, Malaysia. Detailed demographic data, ECOG (Eastern Cooperation Oncology Group) performance status, stage of disease and treatment were recorded. The date of histology or cytology confirmation was used as the date of entry. Survival time was calculated from the date of entry to the date of death. RESULTS:One hundred forty-nine patients were included for survival analysis. The median age was 62 years and patients were predominantly males (78%) and smokers (78%). The majority had non-small cell lung cancer (NSCLC) (94%); only six patients (4%) had small cell lung cancer. All patients presented with stage 3 or stage 4 disease. Overall median survival was 18 weeks. "No definitive treatment" and "ECOG 3-4" were the significant independent predictors of death, with the hazard ratios of 2.1 (95% confidence interval [CI] 1.4, 3.0) and 1.6 (95% CI 1.1, 2.3) times, respectively. Among NSCLC patients on treatment, 1- and 2-year survival rates were 27% and 15%, respectively. CONCLUSION:The majority of lung cancer patients in Pahang presented with advanced disease. No definitive treatment and ECOG 3-4 were independent poor prognostic factors.
journal_name
Asia Pac J Clin Oncoljournal_title
Asia-Pacific journal of clinical oncologyauthors
How SH,Ng TH,Kuan YC,Jamalludin AR,Fauzi ARdoi
10.1111/ajco.12179subject
Has Abstractpub_date
2015-09-01 00:00:00pages
221-7issue
3eissn
1743-7555issn
1743-7563journal_volume
11pub_type
杂志文章abstract：AIMS:Esophageal cancer (EC) is one of the most prevalent and deadly cancers worldwide. Along with nutrition, smoking and alcohol consumption, human papillomavirus (HPV) infection is one of the major risk factors, which is modulated by host immune response. This study is aimed at elucidating how HPV modifies host immune...
journal_title：Asia-Pacific journal of clinical oncology
pub_type： 杂志文章
doi：10.1111/ajco.12135
更新日期：2014-03-01 00:00:00
abstract：AIM:To carry out a nationwide study of KRAS testing in metastatic colorectal cancer as reported by nine major molecular pathology service providers in Australia, including mutation frequencies and turnaround times that might impact on patient care. METHODS:Participating laboratories contributed information on KRAS mut...
journal_title：Asia-Pacific journal of clinical oncology
pub_type： 杂志文章
doi：10.1111/ajco.12201
更新日期：2014-09-01 00:00:00
abstract：AIM:To assess the prognostic significance of enhancement rate (ER) measured by contrast-enhanced ultrasonography (CEUS) in patients with hepatocellular carcinoma (HCC) undergoing radiofrequency ablation (RFA). MATERIALS AND METHODS:A total of 253 patients with single primary HCC undergoing preoperative CEUS and RFA we...
journal_title：Asia-Pacific journal of clinical oncology
pub_type： 杂志文章
doi：10.1111/ajco.13157
更新日期：2019-08-01 00:00:00
abstract：AIMS:To evaluate the response and progression-free survival (PFS) of Malaysian patients with advanced lung adenocarcinoma and unknown epidermal growth factor receptor (EGFR) mutation status treated with gefitinib. METHODS:A retrospective analysis of consecutive patients with EGFR mutation unknown stage III or IV lung ...
journal_title：Asia-Pacific journal of clinical oncology
pub_type： 杂志文章
doi：10.1111/j.1743-7563.2011.01509.x
更新日期：2012-09-01 00:00:00
abstract：AIMS:Wilms tumor (WT) is rare in Asia. Treatment of bilateral WT is challenging, and the treatment outcome of bilateral WT is rarely reported in low incidence areas. METHODS:We enrolled patients with bilateral WT registered in Chang Gung Memorial Hospital, Taoyuan, Taiwan, between January 1986 and June 2015. They were...
journal_title：Asia-Pacific journal of clinical oncology
pub_type： 杂志文章
doi：10.1111/ajco.12501
更新日期：2016-09-01 00:00:00
abstract：AIM:This systematic review and meta-analysis was performed to assess the efficacy and side effects between single-agent and doublet chemotherapy in first-line treatment of advanced non-small cell lung cancer with performance status 2 (PS2). METHODS:We searched for randomized controlled trials in online electronic data...
journal_title：Asia-Pacific journal of clinical oncology
pub_type： 杂志文章,meta分析,评审
doi：10.1111/ajco.12359
更新日期：2015-09-01 00:00:00
abstract：:The COVID-19 pandemic will present a range of challenges to radiation oncology departments. Early data suggest that cancer patients carry a higher than average, but still low absolute risk of hospitalization from COVID-19. The risk of severe events for those who are hospitalized however, is high. Resources for usual c...
journal_title：Asia-Pacific journal of clinical oncology
pub_type： 杂志文章,评审
doi：10.1111/ajco.13456
更新日期：2021-02-01 00:00:00
abstract：INTRODUCTION:The goal of this study was to determine the relationships among type 2 diabetes mellitus (DM), specific cancer histological types and mortality in hospitalized women. METHODS:Patients over 19 years of age were included if the indication for hospital admission was a diagnosis of type 2 DM or a malignancy. ...
journal_title：Asia-Pacific journal of clinical oncology
pub_type： 杂志文章
doi：10.1111/ajco.12084
更新日期：2016-03-01 00:00:00
abstract：:Resistance to endocrine therapy is a significant therapeutic challenge in the treatment of women with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer. Cyclin-dependent kinase (CDK)4/6 inhibitors in combination with endocrine therapy have been shown to i...
journal_title：Asia-Pacific journal of clinical oncology
pub_type： 杂志文章
doi：10.1111/ajco.13064
更新日期：2018-10-01 00:00:00
abstract：:First-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are used as first-line therapy in patients with non-small cell lung cancer (NSCLC) harboring a sensitizing mutation in the EGFR gene. Unfortunately, resistance to these therapies often occurs within 10 months of commencing treat...
journal_title：Asia-Pacific journal of clinical oncology
pub_type： 杂志文章,评审
doi：10.1111/ajco.12699
更新日期：2017-08-01 00:00:00
abstract：AIM:For several decades urinary arylsulfatase (ARS) activity has been reported to be elevated in many cancers. It has been shown that urinary ARS activity may serve as a marker of tumor progression and therapy surveillance. This study was designed to evaluate the clinical application of detection of urinary ARS activit...
journal_title：Asia-Pacific journal of clinical oncology
pub_type： 杂志文章
doi：10.1111/j.1743-7563.2012.01545.x
更新日期：2012-12-01 00:00:00
abstract：AIM:Retroperitoneal sarcomas (RPSs) are large, rare tumors. The role of core biopsy for retroperitoneal masses identified by preoperative imaging is unclear and we report the safety and accuracy of core biopsies at a specialized sarcoma unit in Sydney, Australia. METHODS:A retrospective analysis of a prospectively col...
journal_title：Asia-Pacific journal of clinical oncology
pub_type： 杂志文章
doi：10.1111/ajco.12125
更新日期：2016-03-01 00:00:00
abstract：BACKGROUND:Definitive chemoradiotherapy (CRT) is the standard treatment for locally advanced head and neck cancer (HNC). However, for very elderly patients, the comparison of benefit/risk between definitive radiotherapy (RT) with and without systemic chemotherapy was equivocal. PATIENTS AND METHODS:The study was a sin...
journal_title：Asia-Pacific journal of clinical oncology
pub_type： 杂志文章
doi：10.1111/ajco.12764
更新日期：2018-06-01 00:00:00
abstract：AIM:To investigate the association between plasma visfatin levels and risk of early and advanced colorectal cancer (CRC). METHODS:In total, 358 CRC patients and 286 controls were enrolled. According to the T factor of the TNM system. cancer patients were divided into two subgroups: early and advanced cancer. Levels of...
journal_title：Asia-Pacific journal of clinical oncology
pub_type： 杂志文章
doi：10.1111/ajco.12090
更新日期：2016-03-01 00:00:00
abstract：AIM:This study examined pathological quality-of-surgery indicators in laparoscopic and open rectal cancer resection specimens. METHODS:Retrospective analysis of consecutive, prospectively recorded laparoscopic (LR) or open (OR) resections for rectal cancer. Indicators included integrity of the perirectal fascial envel...
journal_title：Asia-Pacific journal of clinical oncology
pub_type： 杂志文章
doi：10.1111/ajco.12781
更新日期：2018-04-01 00:00:00
abstract：OBJECTIVE:To review the outcomes of metastatic melanoma patients treated with infliximab for severe steroid-refractory colitis secondary to ipilimumab therapy. BACKGROUND:Immune-related colitis is a known potential adverse effect of ipilimumab, that causes significant morbidity and extended hospital stays. There are l...
journal_title：Asia-Pacific journal of clinical oncology
pub_type： 杂志文章
doi：10.1111/ajco.12651
更新日期：2017-10-01 00:00:00
abstract：BACKGROUND:Neutrophil count reduction after chemotherapy has been related with longer survival of patients with metastatic pancreatic adenocarcinoma, but there is not a standardized measurement for this phenomenon. METHODS:Some parameters related to the change in neutrophil count between the first and the second cycle...
journal_title：Asia-Pacific journal of clinical oncology
pub_type： 杂志文章
doi：10.1111/ajco.13325
更新日期：2020-08-01 00:00:00
abstract：PURPOSE:Mitomycin C (MMC) plus standard 5-fluorouracil (FU) infusion in weeks 1 and 5 often contributes to radiotherapy interruptions and possibly less-than-ideal outcomes in anal cancer. This study was to evaluate alternative strategies for chemotherapy delivery that might be less toxic or more efficacious, and outcom...
journal_title：Asia-Pacific journal of clinical oncology
pub_type： 杂志文章
doi：10.1111/ajco.13106
更新日期：2019-02-01 00:00:00
abstract：:For advanced and metastatic urothelial carcinomas (UCs), platinum (preferably cisplatin)-based chemotherapy has been the standard treatment for many years. However, many patients are ineligible for cisplatin-based chemotherapy because of poor performance status and/or other age-related conditions. At the other end of ...
journal_title：Asia-Pacific journal of clinical oncology
pub_type： 杂志文章,评审
doi：10.1111/ajco.13312
更新日期：2020-09-01 00:00:00
abstract：AIM:A viable and sustainable medical oncology profession is integral for meeting the increasing demand for quality cancer care. The aim of this study was to explore the workforce-related experiences, perceptions and career expectations of early-career medical oncologists in Australia. METHODS:A mixed-methods design, i...
journal_title：Asia-Pacific journal of clinical oncology
pub_type： 杂志文章
doi：10.1111/ajco.12844
更新日期：2018-10-01 00:00:00
abstract：BACKGROUND:Metastatic colorectal cancer (mCRC) patients with a right-sided primary (RC) have an inferior survival to mCRC arising from a left-sided primary (LC). Previous analyses have suggested multiple factors contribute. METHODS:The Treatment of Recurrent and Advanced Colorectal Cancer (TRACC) Registry prospectivel...
journal_title：Asia-Pacific journal of clinical oncology
pub_type： 杂志文章
doi：10.1111/ajco.13135
更新日期：2019-06-01 00:00:00
abstract：BACKGROUND:Docetaxel is an effective therapy for metastatic castration-resistant prostate cancer (mCRPC); however, many patients experience febrile neutropenia (FN) and cease treatment early due to toxicity. It is not known whether lower dose (LD) q3-weekly docetaxel impacts toxicity or efficacy. METHODS:Multicenter r...
journal_title：Asia-Pacific journal of clinical oncology
pub_type： 杂志文章,多中心研究
doi：10.1111/ajco.12840
更新日期：2018-10-01 00:00:00
abstract：AIM:Long noncoding RNAs play a key role in the development and progression of various human cancers. Recently, LINC00852 has been reported to be associated with spinal metastasis lung adenocarcinoma. However, the role and potential mechanisms of LINC00852 in prostate cancer cells remain largely unknown. METHODS:LINC00...
journal_title：Asia-Pacific journal of clinical oncology
pub_type： 杂志文章
doi：10.1111/ajco.13418
更新日期：2020-10-30 00:00:00
abstract：AIM:To evaluate predictive factors which associated with oncological outcomes to first-line axitinib for metastatic renal cell carcinoma (mRCC). METHODS:A retrospective chart review was conducted patients who had been treated with axitinib as first-line therapy for the treatment of mRCC from September 2013 to February...
journal_title：Asia-Pacific journal of clinical oncology
pub_type： 杂志文章
doi：10.1111/ajco.13323
更新日期：2020-08-01 00:00:00
abstract：AIM:Colorectal cancer (CRC) is one of the most common malignancies worldwide and adjuvant chemotherapy is proven to improve survival in patients with Dukes' C CRC. The purpose of this study was to analyze factors influencing referral to medical oncology in patients with Dukes' C colonic cancer in our institutions. MET...
journal_title：Asia-Pacific journal of clinical oncology
pub_type： 杂志文章
doi：10.1111/j.1743-7563.2010.01312.x
更新日期：2010-09-01 00:00:00
abstract：:Carboplatin is a platinum analogue, widely used in the treatment of numerous cancer types including lung, genitourinary and ovarian cancers. It is also used in the adjuvant treatment of human epidermal growth factor receptor 2 positive breast cancer, where a non-anthracycline regimen is preferred. It is considered gen...
journal_title：Asia-Pacific journal of clinical oncology
pub_type： 杂志文章
doi：10.1111/j.1743-7563.2012.01526.x
更新日期：2012-09-01 00:00:00
abstract：AIM:The role of germline testing in prostate cancer is evolving and knowledge of an individual's genetic profile may be used to guide not only an assessment of their familial risk but also have prognostic and therapeutic implications. Although international guidelines have incorporated recommendations for germline test...
journal_title：Asia-Pacific journal of clinical oncology
pub_type： 杂志文章
doi：10.1111/ajco.13148
更新日期：2019-08-01 00:00:00
abstract：AIM:The purpose of this study was to investigate the impact of subcarinal dissection on short-term outcome and survival following esophagectomy in patients with thoracic esophageal squamous cell carcinoma. METHODS:A total of 2252 patients underwent an esophagectomy for esophageal cancer from January 1997 to December 2...
journal_title：Asia-Pacific journal of clinical oncology
pub_type： 杂志文章
doi：10.1111/ajco.12095
更新日期：2014-06-01 00:00:00
abstract：BACKGROUND:Common diseases with potential to increase the risk of death from lung cancer have so far not been studied in large populations. METHODS:We did a population-based retrospective cohort study using nationwide health insurance claims data from 2005 to 2012 in Korea including 205 403 lung cancer patients. Multi...
journal_title：Asia-Pacific journal of clinical oncology
pub_type： 杂志文章
doi：10.1111/ajco.12697
更新日期：2018-04-01 00:00:00
abstract：AIM:To describe the development of the content and pilot testing of a radiation therapist-led educational intervention for breast cancer patients about to commence radiotherapy. Pilot testing consisted of testing the intervention for appropriateness, feasibility and acceptance. METHODS:A tailored intervention consisti...
journal_title：Asia-Pacific journal of clinical oncology
pub_type： 临床试验,杂志文章
doi：10.1111/j.1743-7563.2012.01520.x
更新日期：2012-09-01 00:00:00
